Pegavision Corp
TWSE:6491
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
367
532
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Pegavision Corp
Gain/Loss on Disposition of Assets
Pegavision Corp
Gain/Loss on Disposition of Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Gain/Loss on Disposition of Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
P
|
Pegavision Corp
TWSE:6491
|
Gain/Loss on Disposition of Assets
-NT$101k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SciVision Biotech Inc
TWSE:1786
|
Gain/Loss on Disposition of Assets
NT$190k
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
||
OK Biotech Co Ltd
TWSE:4155
|
Gain/Loss on Disposition of Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Pegavision Corp
Glance View
Pegavision Corp. focusing on research, development, manufacture and marketing of soft contact lenses and the medical optic devices. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2014-12-30. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Pegavision Corp's Gain/Loss on Disposition of Assets?
Gain/Loss on Disposition of Assets
-101k
TWD
Based on the financial report for Jun 30, 2024, Pegavision Corp's Gain/Loss on Disposition of Assets amounts to -101k TWD.